Randomized clinical trial: effect of the 5‐HT4 receptor agonist revexepride on reflux parameters in patients with persistent reflux symptoms despite PPI treatment

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2982|27|2|258-268

ISSN： 1350-1925

Source： NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol.27, Iss.2, 2015-02, pp. : 258-268

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 649-661

John Wiley & Sons Inc

Access to resources Recommend Favorite

Majority of symptoms in esophageal reflux PPI non‐responders are not related to reflux

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 11, 2015-11 ,pp. : 1667-1674

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone on Peripheral Vessel Function and Clinical Parameters in Nondiabetic Patients: A Double-Center, Randomized Controlled Pilot Trial

By  

Cardiology, Vol. 131, Iss. 3, 2015-05 ,pp. : 165-171

Karger

Access to resources Recommend Favorite

Lack of effect of the glucagon‐like peptide‐1 receptor agonist liraglutide on psoriasis in glucose‐tolerant patients – a randomized placebo‐controlled trial

By  

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY & VENEREOLOGY, Vol. 29, Iss. 3, 2015-03 ,pp. : 555-559

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of 5‐hydroxytryptamine receptor 4 agonist mosapride on human gastric accommodation

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 9, 2015-09 ,pp. : 1303-1309

John Wiley & Sons Inc

Access to resources Recommend Favorite